Home/Filings/4/0001415889-20-002181
4//SEC Filing

SAXE JON S 4

Accession 0001415889-20-002181

CIK 0001411685other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 4:31 PM ET

Size

5.8 KB

Accession

0001415889-20-002181

Insider Transaction Report

Form 4
Period: 2020-08-21
SAXE JON S
Director
Transactions
  • Purchase

    Common Stock

    2020-08-21$0.69/sh+30,000$20,70050,000 total(indirect: By Trust)
Holdings
  • Common Stock

    3,251
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.678 to $0.697, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0001114914

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:31 PM ET
Size
5.8 KB